2026 Independent Medical Education Call for Grants supports primary care physicians through certified Alzheimer’s education to strengthen early detection, culturally sensitive care, and care connections.
Funder: Roche
Due Dates: October 30, 2026 (Full proposal) | November 10, 2026 (Decision notification by)
Funding Amounts: Up to $200,000 for each of two Alzheimer’s disease education opportunities
Summary: Supports independent, certified education for primary care physicians to improve cognitive assessment, early Alzheimer’s detection, and culturally sensitive care.
Key Information: Applicants must be U.S.-based, accredited CME/CE providers in good standing with a registered gFRS account.
The Independent Medical Education team at Genentech, a member of the Roche Group, supports independent, certified education that improves patient care by strengthening healthcare professionals’ knowledge, competence, and performance. This call focuses on evidence-based educational gaps in Alzheimer’s disease care in U.S. primary care settings.
Two opportunities address complementary needs. The first supports community primary care physicians in discussing brain health, assessing cognitive risk, distinguishing mild cognitive impairment from normal aging using validated tools, and understanding blood-based biomarkers. The second supports physicians serving underserved populations through culturally sensitive communication, low-bias cognitive assessments, and community resource mapping. Together, these priorities aim to strengthen early detection, reduce stigma, and connect patients with appropriate care pathways.